LifeStance Health Group Projects Mid-Teens Revenue Growth Through 2027
LifeStance Health Group (LFST) reported strong momentum in its third quarter, marking the second consecutive quarter of revenue growth exceeding 25%. CEO David Bourdon characterized the period as a tremendous success for the company across all business segments. Looking ahead to 2027, the company has outlined long-term revenue growth targets toward the lower end of the mid-teens range. This guidance includes accounting for a projected 1-2 point headwind related to Electronic Health Record (EHR) transitions.
Tickers: $LFST
Topics: management commentary quarterly earnings revenue growth